“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit Follow Mineralys on LinkedIn, Twitter and Bluesky”

Mineralys is a fully remote company.

The Director of Accounting is a key leadership role within the growing Finance organization, responsible for overseeing the general ledger. This role will lead the build‑out and ongoing optimization of our accounting infrastructure to support commercial product launch, revenue recognition under ASC 606, inventory and cost of goods sold (COGS) accounting, and gross‑to‑net (GTN) p...